About QVigilance
QVigilance is a company based in Hitchin (United Kingdom) founded in 2010. It operates as a B2B. QVigilance offers products and services including Case Processing, Literature Screening, Periodic Reporting, Signal Management, and Regulatory Intelligence. QVigilance operates in a competitive market with competitors including Navitas Life Sciences, Centice, Arakis, Serend-ip and Oviya MedSafe, among others.
- Headquarter Hitchin, United Kingdom
- SectorsHealthcare
- Email••••••••
- Website qvigilance.com
- Social LinkedIn X
Products & Services of QVigilance
QVigilance offers a comprehensive portfolio of products and services, including Case Processing, Literature Screening, Periodic Reporting, Signal Management, and Regulatory Intelligence.
Handles adverse event reporting for drugs and devices.
Searches and reviews global literature for safety concerns.
Prepares reports like DSURs and PSURs for compliance.
Detects and manages safety signals per GVP guidelines.
Tracks updates from regulatory authorities worldwide.
Competitors of QVigilance
QVigilance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Navitas Life Sciences, Centice, Arakis, Serend-ip and Oviya MedSafe, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| navitaslifesciences.com | 1986 | Princeton, United States | – | 5 | Clinical, regulatory, safety and compliance services for clinical development | |
| centice.com | 2004 | Morrisville, United States | $40.82M | – | Develops computational sensor technology for various applications. | |
| arakis.com | 2000 | Cambridge, United Kingdom | – | – | Arakis was founded in 2000 in Cambridge, United Kingdom. | |
| serend-ip.de | 2011 | Munster, Germany | – | – | Nanoscale cell surface topography is quantified via research expertise. | |
| oviyamedsafe.com | 2012 | Coimbatore, India | – | 28 | Delivers pharmacovigilance consulting and drug safety services to ensure regulatory compliance. | |
| apcerls.com | 2007 | Princeton, United States | – | 24 | Offers pharmacovigilance, medical information, and regulatory affairs services to biotech firms worldwide. | |
| primevigilance.com | 2008 | Guildford, United Kingdom | – | – | Functional CRO offering pharmacovigilance services | |
| regulatoryhouse.com | 2012 | Brno, Czech Republic | – | – | Provides regulatory and pharmacovigilance services for health products and compliance in Europe. |
Detailed competitors of QVigilance
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to QVigilance
10 companies that operate in the same segment as QVigilance (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about QVigilance
QVigilance was founded in 2010.
QVigilance is headquartered in Hitchin, United Kingdom. It is registered at Hitchin, Hertfordshire, United Kingdom.
QVigilance is a pharmacovigilance service provider specializing in biopharmaceuticals, handling adverse event processing, literature screening, and periodic reporting to maintain compliance with EMA and FDA regulations. It supports global clients through risk management and regulatory intelligence services. Based primarily in the UK, with offices in Poland and India, the company partners with pharmaceutical firms to safeguard patient safety and meet international standards.
QVigilance's top competitors include Navitas Life Sciences, PrimeVigilance and Arakis.
QVigilance offers Case Processing, Literature Screening, Periodic Reporting, Signal Management, and Regulatory Intelligence.